HK1253768A1 - 四碘甲狀腺原氨酸的液體藥物製劑 - Google Patents

四碘甲狀腺原氨酸的液體藥物製劑

Info

Publication number
HK1253768A1
HK1253768A1 HK18104913.6A HK18104913A HK1253768A1 HK 1253768 A1 HK1253768 A1 HK 1253768A1 HK 18104913 A HK18104913 A HK 18104913A HK 1253768 A1 HK1253768 A1 HK 1253768A1
Authority
HK
Hong Kong
Prior art keywords
tetraiodothyronine
pharmaceutical formulations
liquid pharmaceutical
liquid
formulations
Prior art date
Application number
HK18104913.6A
Other languages
English (en)
Inventor
Rosa Mario De
Chiara Schiraldi
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon Sa filed Critical Altergon Sa
Publication of HK1253768A1 publication Critical patent/HK1253768A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
HK18104913.6A 2015-05-19 2018-04-16 四碘甲狀腺原氨酸的液體藥物製劑 HK1253768A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB20150707 2015-05-19
PCT/IB2016/052860 WO2016185378A1 (en) 2015-05-19 2016-05-17 Liquid pharmaceutical formulations of tetraiodothyronine

Publications (1)

Publication Number Publication Date
HK1253768A1 true HK1253768A1 (zh) 2019-07-05

Family

ID=53765440

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18104913.6A HK1253768A1 (zh) 2015-05-19 2018-04-16 四碘甲狀腺原氨酸的液體藥物製劑

Country Status (6)

Country Link
US (3) US20170105955A1 (zh)
EP (1) EP3297677B1 (zh)
CN (1) CN107635546B (zh)
CA (1) CA2986095A1 (zh)
HK (1) HK1253768A1 (zh)
WO (1) WO2016185378A1 (zh)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3808332A (en) * 1969-01-27 1974-04-30 Armour Pharma Pharmaceutical compositions containing the reaction product of a tertiary phosphine with thyroxine
ITMI20011401A1 (it) * 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei
ITMI20022777A1 (it) * 2002-12-27 2004-06-28 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
CN1820783A (zh) * 2005-02-17 2006-08-23 阿尔特贡股份公司 甲状腺激素药物制剂
GR1008017B (el) * 2012-08-03 2013-10-24 Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων, Σταθερο φαρμακευτικο συστημα (κιτ) για την παρασκευη ποσιμου διαλυματος λεβοθυροξινης ή φαρμακευτικως αποδεκτου αλατος αυτης

Also Published As

Publication number Publication date
CN107635546A (zh) 2018-01-26
US20180289650A1 (en) 2018-10-11
CN107635546B (zh) 2020-08-25
US20200246297A1 (en) 2020-08-06
WO2016185378A1 (en) 2016-11-24
EP3297677B1 (en) 2023-07-12
US20170105955A1 (en) 2017-04-20
EP3297677A1 (en) 2018-03-28
CA2986095A1 (en) 2016-11-24

Similar Documents

Publication Publication Date Title
ZA201808476B (en) Stable liquid pharmaceutical preparation
ZA201901590B (en) Liquid pharmaceutical composition
IL287947A (en) Viscosity reduction of pharmaceutical preparations
SI4070787T1 (sl) Farmacevtske formulacije
HK1254343A1 (zh) 藥物製劑
HUE054858T2 (hu) Folyékony gyógyszerészeti készítmény
HUE050783T2 (hu) Folyékony levotiroxin készítmények
IL253177A0 (en) Pharmacy preparation
HK1245653A1 (zh) 藥物製劑
ZA201707094B (en) Pharmaceutical formulations
GB201718468D0 (en) Stable liquid pharmaceutical compositions of bortezomb
IL267279A (en) Pharmaceutical formulations of suvorexant
GB201506755D0 (en) Novel pharmaceutical formulation
GB201511246D0 (en) Pharmaceutical formulation
HK1253768A1 (zh) 四碘甲狀腺原氨酸的液體藥物製劑
IL253572A0 (en) A liquid pharmaceutical preparation